跳至主要内容
临床试验/NCT04837261
NCT04837261已完成不适用

Shortening Duration of Antiarrhythmic Medication for SVT in Infants

Tampere University Hospital18 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2021年4月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
107
试验地点
18
主要终点
Recurrence of SVT after antiarrhythmic medication

研究概览

简要总结

The infants diagnosed with SVT are treated with antiarrhythmic medication to prevent the recurrence of SVT. This prospective observational cohort study evaluates efficacy and safety of shortening duration of antiarrhythmic medication to four months in infants with SVT. Primary outcome is incidence of recurrent SVT in infants after 4 months of antiarrhythmic medication compared to retrospectively reviewed cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Age 6 months or less
  • Documented SVT due to AVRT or AVNRT

排除标准

  • Age > 6 months
  • Ectopic atrial tachycardia
  • Atrial flutter
  • Atrial fibrillation
  • Permanent junctional reciprocating tachycardia

结局指标

主要结局

Recurrence of SVT after antiarrhythmic medication

时间窗: 1 year follow-up

次要结局

  • Proportion of participants with treatment failure(4 months of antiarrhythmic medication)
  • Prevalence of adverse events(4 months of antiarrhythmic medication)
  • Recurrence of SVT after one year follow-up(5 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验